MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock in...
$258,750K
Proceeds from the
exercise of stock options
$1,958K
Net cash provided by
financing activities
$244,664K
Canceled cashflow
$16,044K
Net (decrease)
increase in cash, cash...
-$26,549K
Canceled cashflow
$244,664K
Sales of marketable
securities
$100,826K
Maturities of marketable
securities
$58,550K
In-process research and
development expenses
$150,000K
Stock-based compensation
expense
$8,460K
Accounts payable
$1,182K
Depreciation and
amortization
$723K
Prepaid expenses and
other current and...
-$175K
Issuance costs
associated with...
$16,044K
Net cash (used in)
provided by investing...
-$243,830K
Canceled cashflow
$159,376K
Net cash used in
operating activities
-$27,383K
Canceled cashflow
$160,540K
Purchases of marketable
securities
$253,170K
In-process research and
development
$150,000K
Purchases of property and
equipment
$36K
Net loss
-$183,440K
Accrued expenses and
other current and...
-$3,269K
Accretion on marketable
securities, net
$746K
Operating lease assets and
liabilities, net
$421K
Realized gain from sales
of marketable...
$47K
Back
Back
Cash Flow
Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS)
source: myfinsight.com